Article
Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract - 1 Feb 2011
Yuan Ray-Hwang, Jeng Yung-Ming, Hu Rey-Heng, Lai Po-Lin, Lee Po-Huang, Cheng Chia-Chi, Hsu Hey-Chi
Abstract excerpt
BACKGROUND: Cytokeratin 19 (CK19), a molecular marker of hepatic progenitor cells and cholangiocytes, is expressed in hepatocellular carcinomas (HCC), but not in normal hepatocytes. However, role of CK19 in HCC progression, especially when interacted with p53 and β-catenin mutations, remained largely unknown. MATERIALS AND METHODS: From January 1983 to December 1997, 210 surgically resected, unifocal, primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
